Imperial Cancer Polyclinic is committed to providing personalized consultation and comprehensive treatment options with a specialist medical team from Imperial College London School of Medicine, Imperial College London, Philipps-Universität Marburg (Germany) School of Medicine, National Taiwan University Hospital, and Kaohsiung Medical University. Next-generation sequencing (NGS) and drug sensitivity test of circulating tumor cells aim to determine an optimal therapy for each individual patient.
We now have more than 30 medical researchers, including scientists with Ph.D. and Master’s degrees in various biomedical fields, engaging in studies of tumor immunotherapy, intra-arterial chemotherapy, cancer genomics analyses, cancer-antigen targeted therapies and genetic engineering techniques for highly individualized precision medicine.
In addition to the operation room, observation room and recovery room for professional surgical services, the Imperial Cancer Polyclinic also provides patients and their families with warm and comfortable environments for their stay, such as separate, quiet and comfortable areas for waiting, for consultation, for out-patient chemotherapy, for minor surgical procedures, etc., in order to provide the warmest reception and care, and also to protect the privacy.
*Arterial Infusion Chemotherapy (Featured Medical)
Also known as “Localized Chemotherapy”. Intra-arterial administration of chemotherapeutic drugs is based on the "First Pass" effect, injecting directly into the artery supplying the tumor via a pre-embedded arterial catheter. This is suitable for solid cancers localized to the primary site of the body and locally advanced. For example, head, neck, liver, pancreatic, colorectal, urinary tract, ovarian and endometrial cancer would all be suitable.
According to studies intra-arterial administration could not only deliver high intra-tumoral concentration of drugs, reduce the tumor size and improve the efficacy and patient’s survival but also decrease systemic toxicities compared with intravenous administration. In recent times, intra-arterial chemotherapy has been widely used for cancers in oral cavities to shrink some larger cancers before surgery. In some cases, this makes it possible to use less radical surgery and remove less tissue in order to preserve the individuals’ original appearance and physical functions.